OClawVPS.com
EnPlusOne Biosciences
Edit

EnPlusOne Biosciences

https://www.enplusonebio.com/
Last activity: 23.04.2025
Active
Categories: BioTechCommerceInformationManufacturingPlatformResearch
EnPlusOne is on a mission to bring RNA and RNA solutions to the world. Its ezRNA™ synthesis platform is a stepwise innovation that can incorporate a diverse array of nucleotide modifications and promises a manufacturing process that can sustainably deliver therapeutic RNA at commercial scales. In addition to direct RNA synthesis, EnPlusOne's ezRNA™ platform supports a vast array of RNA solution applications. For more information, please visit www.enplusonebio.com
Followers
43
Followers
125
Mentions
5
Location: United States, Massachusetts, Watertown
Employees: 1-10
Total raised: $22M

Investors 1

DateNameWebsite
09.10.2022Breakout V...breakout.v...

Funding Rounds 2

DateSeriesAmountInvestors
19.02.2025-$10M-
30.09.2022Seed$12M-

Mentions in press and media 5

DateTitleDescription
23.04.2025EnPlusOne Biosciences Appoints Clare Murray as CEOEnPlusOne Biosciences, a Watertown, MA-based biotechnology company, announced the appointment of Clare Murray, Ph.D., as Chief Executive Officer. Dr. Murray brings experience in corporate strategy and business development, having led multip...
19.02.2025EnPlusOne Biosciences Raises $10M in FinancingEnPlusOne Biosciences, a Watertown, MA-based biotechnology company empowering enzymes to deliver better RNA at scale, raised $10M in funding. The round was led by Northpond Ventures and Breakout Ventures. As part of their increased investme...
30.09.2022EnPlusOne Biosciences Raises $12M in Seed FinancingEnPlusOne Biosciences, a Watertown, MA-based biotechnology company, raised $12M in Seed funding. The round was led by Northpond Ventures with participation from Breakout Ventures, and Coatue. The company intends to use the funds to build ou...
30.09.2022EnPlusOne Biosciences Inks $12M Seed Round WATERTOWN, MA, EnPlusOne Biosciences, harnessing the power of enzymes to synthesize RNA oligonucleotides, launched with $12 million in seed financing. >> Click here for more funding data on EnPlusOne Biosciences >> To export...
-EnPlusOne Biosciences“Homepage - EnPlusOne Bio”

Reviews 0

Sign up to leave a review

Sign up Log In